文献速递骨显像与常规 SPECT肿瘤 PET/CT

18F-氟化钠PET诊断与监测骨质疏松:可预见未来的必由之路

Diagnosis and Monitoring of Osteoporosis With 18F-Sodium Fluoride PET: An Unavoidable Path for the Foreseeable Future.
PubMed 文献 · Semin Nucl Med · 2018-09-03

本文综述了18F-氟化钠(NaF)PET、NaF-PET/CT及NaF-PET/MRI在腰椎和髋部骨质疏松与骨量减少评估中的应用。NaF-PET通过标准化摄取值测量骨转换,提供代谢改变的分子视角,其敏感性和全身骨骼检查能力优于标准结构成像技术。尚需进一步研究确定其反映代谢性骨病治疗干预疗效的准确性。

要点

  • NaF-PET通过标准化摄取值测量骨转换,提供骨质疏松的分子代谢视角。
  • NaF-PET的敏感性和全身骨骼检查能力使其优于标准结构成像技术。
  • 尚需进一步研究确定NaF-PET反映代谢性骨病治疗疗效的准确性。

核心结论

  • NaF-PET、NaF-PET/CT或NaF-PET/MRI可用于评估腰椎和髋部的骨质疏松与骨量减少,提供骨转换的分子视角。

研究设计与样本

  • 综述,聚焦NaF-PET、NaF-PET/CT或NaF-PET/MRI在腰椎和髋部骨质疏松与骨量减少评估中的应用。

主要发现

  • NaF-PET通过标准化摄取值测量骨转换,提供导致骨骼疾病的代谢改变的分子视角。
  • NaF-PET的敏感性和检查整个骨骼系统的能力使其成为优于标准结构成像技术的成像方式。

关键数值与推荐

  • 当前骨质疏松及其他代谢性骨病主要通过双能X线吸收法评估,罕用四环素标记骨活检或99mTc骨显像。
  • 全球约2亿人患骨质疏松;2005年美国估计因骨质疏松发生超过200万例骨折事件。

临床怎么用

  • NaF-PET、NaF-PET/CT或NaF-PET/MRI可用于腰椎和髋部骨质疏松与骨量减少的评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of metabolic bone diseases particularly osteoporosis and its precursor, osteopenia, continue to grow as serious global health issues today. On a worldwide perspective, 200million people suffer from osteoporosis and in 2005, over 2million fracture incidents were estimated due to osteoporosis in the United States. Currently, osteoporosis and other metabolic bone diseases are evaluated primarily through dual energy X-ray absorptiometry, and rarely by bone biopsy with tetracycline labeling or Technetium-99m (99mTc) based bone scintigraphy. Deficiencies in these methods have prompted the use of more precise methods of assessment. This review highlights the use of 18F-sodium fluoride (NaF) with PET (NaF-PET), NaF-PET/CT, or NaF-PET/MRI in the evaluation of osteoporosis and osteopenia in the lumbar spine and hip. This imaging modality provides a molecular perspective with respect to the underlying metabolic alterations that lead to osseous disorders by measuring bone turnover through standardized uptake values. Its sensitivity and ability to examine the entire skeletal system make it a more superior imaging modality compared to standard structural imaging techniques. Further research is needed to determine its accuracy in reflecting the efficacy of therapeutic interventions in metabolic bone diseases.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Reilly CC, Raynor WY, Hong AL, et al. Diagnosis and Monitoring of Osteoporosis With 18F-Sodium Fluoride PET: An Unavoidable Path for the Foreseeable Future. Semin Nucl Med. 2018. PMID: 30322479. doi:10.1053/j.semnuclmed.2018.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。